Retraction: Dysregulation of survivin-targeting microRNAs in autoimmune diseases: new perspectives for novel therapies
- 1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
- 2Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
- 3Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
- 4Medical Laboratory Technology Department, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia
- 5Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran
- 6Department of Immunology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran
- 7German Cancer Research Center, Toxicology and Chemotherapy Unit (G401), Heidelberg, Germany
Citation: Shomali N, Suliman Maashi M, Baradaran B, Daei Sorkhabi A, Sarkesh A, Mohammadi H, Hemmatzadeh M, Marofi F, Sandoghchian Shotorbani S and Jarahian M (2022) Dysregulation of Survivin-Targeting microRNAs in Autoimmune Diseases: New Perspectives for Novel Therapies. Front. Immunol. 13:839945. doi: 10.3389/fimmu.2022.839945
Received: 20 December 2021; Accepted: 14 February 2022;
Published: 03 March 2022; Retracted: 04 September 2023.
Edited by:
Maria I. Bokarewa, University of Gothenburg, SwedenReviewed by:
Amir Sharabi, Beth Israel Deaconess Medical Center and Harvard Medical School, United StatesPablo C. Ortiz-Lazareno, Centro de Investigación Biomédica de Occidente (CIBO), Mexico